Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E6011 Phase 1/2 in Japanese RA Patients
NCT02196558Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2014
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of quetmolimab in rheumatoid arthritis (RA), sponsored by Eisai Co., Ltd.. Started May 2014; status: completed.
02
Drugs
quetmolimab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02196558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196558.